Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists-Reference-Cited by-同舟云学术

Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists

Author:

Cao Yongkai¹²³⁴⁵,Sun Ningning⁵⁶⁷⁸,Zhang Jiumei⁹¹⁰⁴,Liu Zhiguo¹¹¹²¹³⁴,Tang Yi-zhe⁹¹⁰⁴,Wu Zhengzhi⁹¹⁰⁴,Kim Kyeong-Man⁵⁶⁷⁸,Cheon Seung Hoon⁵⁶⁷⁸^ORCID

Affiliation:

1. Integrated Chinese and Western Medicine Postdoctoral Research Station

2. Jinan University

3. Guangzhou 510632

4. China

5. College of Pharmacy and Research Institute of Drug Development

6. Chonnam National University

7. Gwangju 500-757

8. Republic of Korea

9. The Fist Affiliated Hospital of Shenzhen University

10. Shenzhen 518035

11. Chemical Biology Research at School of Pharmaceutical sciences

12. Wenzhou Medical University

13. Wenzhou 325035

Abstract

The dopamine D₃ receptor (D₃R) is a proven therapeutic target for the treatment of neurological and neuropsychiatric disorders.

Funder

National Research Foundation of Korea

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

Reference34 articles.

3. M. Johnson and A.Dutta , D3 Receptor Agonists and Antagonists as Anti-Parkinsonian Threapeutic Agents , RSC Publishing , Cambridge, UK , 2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献